Archives des Endocrinology - Cegedim Health Data

Safety of Non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: a cohort study.

Cea-Soriano L, García-Rodríguez LA, Brodovicz KG, Masso Gonzalez E, Bartels DB, Hernández-Díaz S.

Endocrinology PharmacoEpidemiology

Diabetes, Obesity, Metabolism 2018 10.1111/dom.13275

Read the publication

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Nirantharakumar K, Mohammed N, Toulis KA, Thomas GN, Narendran P.

Endocrinology

Diabetologia 2018 10.1007/s00125-018-4574-6

Read the publication

Initiation of dapagliflozin and treatment-emergent fractures.

Toulis KA, Bilezikian JP, Thomas GN, Hanif W, Kotsa K, Thayakaran R, Keerthy D, Tahrani AA, Nirantharakumar K.

Endocrinology Musculoskeletal disorders PharmacoEpidemiology

Diabetes, Obesity, Metabolism 2018 10.1111/dom.13176.

Read the publication

Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes.

Guest JF, Fuller GW, Vowden P.

Endocrinology

International Wound Journal 2018 10.1111/iwj.12816.

Read the publication

Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs.

Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL, Lo Re V 3rd.

Endocrinology PharmacoEpidemiology

Pharmacoepidemiology Drug Safety 2017 10.1002/pds.4368. [Epub ahead of print]

Read the publication

Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.

Sharma M, Beckley, N, Nazareth I, Petersen I

Endocrinology PharmacoEpidemiology

BMJ Open 2017 10.1136/bmjopen-2017-017260

Read the publication

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.

Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL.

Endocrinology PharmacoEpidemiology

BMJ Open 2017 10.1136/bmjdrc-2017-000400

Read the publication

Psoriasis and the risk of diabetes: A prospective population-based cohort study

Marilyn T.WanMBChB, MPHaDaniel B.ShinPhDaRebecca A.HubbardPhDbMegan H.NoeMD, MPHaNehal N.MehtaMD, MSCE, FAHAcJoel M.GelfandMD, MSCE

Dermatology Endocrinology

Journal of the American Academy of Dermatology 2017 10.1016/j.jaad.2017.10.1050

Read the publication

Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study

Manuj Sharma, Irwin Nazareth, Irene Petersen

Endocrinology

BMJ Open 2016 10.1136/bmjopen-2015-010210corr1

Read the publication

A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012

Sonia J Coton, Irwin Nazareth, Irene Petersen

Endocrinology Gynecology

BMJ Open 2016 10.1136/bmjopen-2015-009494

Read the publication

An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database.

Sharma M, Petersen I, Nazareth I, Coton SJ

Endocrinology

Clinical Epidemiology 2016 8:373-380

Read the publication

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

Saine ME, Carbonari DM, Newcomb CW, et al.

Endocrinology

BMC Pharmacol toxicol 2015 16(1):8

All publications

Publications: Endocrinology

Safety of Non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: a cohort study.

Cea-Soriano L, García-Rodríguez LA, Brodovicz KG, Masso Gonzalez E, Bartels DB, Hernández-Díaz S.

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Nirantharakumar K, Mohammed N, Toulis KA, Thomas GN, Narendran P.

Initiation of dapagliflozin and treatment-emergent fractures.

Toulis KA, Bilezikian JP, Thomas GN, Hanif W, Kotsa K, Thayakaran R, Keerthy D, Tahrani AA, Nirantharakumar K.

Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes.

Guest JF, Fuller GW, Vowden P.

Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs.

Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL, Lo Re V 3rd.

Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.

Sharma M, Beckley, N, Nazareth I, Petersen I

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.

Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL.

Psoriasis and the risk of diabetes: A prospective population-based cohort study

Marilyn T.WanMBChB, MPHaDaniel B.ShinPhDaRebecca A.HubbardPhDbMegan H.NoeMD, MPHaNehal N.MehtaMD, MSCE, FAHAcJoel M.GelfandMD, MSCE

Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study

Manuj Sharma, Irwin Nazareth, Irene Petersen

A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012

Sonia J Coton, Irwin Nazareth, Irene Petersen

An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database.

Sharma M, Petersen I, Nazareth I, Coton SJ

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

Saine ME, Carbonari DM, Newcomb CW, et al.